A citation-based method for searching scientific literature

Ferdinando Giacco, Michael Brownlee. Circ Res 2010
Times Cited: 2451







List of co-cited articles
498 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Diabetes mellitus and oxidative stress-A concise review.
Ullah Asmat, Khan Abad, Khan Ismail. Saudi Pharm J 2016
393
6

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.
N H Cho, J E Shaw, S Karuranga, Y Huang, J D da Rocha Fernandes, A W Ohlrogge, B Malanda. Diabetes Res Clin Pract 2018
6

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
5

Mechanisms of diabetic complications.
Josephine M Forbes, Mark E Cooper. Physiol Rev 2013
5

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
5

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
5

Cellular death, reactive oxygen species (ROS) and diabetic complications.
Caroline Maria Oliveira Volpe, Pedro Henrique Villar-Delfino, Paula Martins Ferreira Dos Anjos, José Augusto Nogueira-Machado. Cell Death Dis 2018
302
5

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.
T Nishikawa, D Edelstein, X L Du, S Yamagishi, T Matsumura, Y Kaneda, M A Yorek, D Beebe, P J Oates, H P Hammes,[...]. Nature 2000
5


Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I.
Francesco Paneni, Joshua A Beckman, Mark A Creager, Francesco Cosentino. Eur Heart J 2013
497
5


Changes in diabetes-related complications in the United States, 1990-2010.
Edward W Gregg, Yanfeng Li, Jing Wang, Nilka Rios Burrows, Mohammed K Ali, Deborah Rolka, Desmond E Williams, Linda Geiss. N Engl J Med 2014
906
4

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
Francesco Cosentino, Peter J Grant, Victor Aboyans, Clifford J Bailey, Antonio Ceriello, Victoria Delgado, Massimo Federici, Gerasimos Filippatos, Diederick E Grobbee, Tina Birgitte Hansen,[...]. Eur Heart J 2020
921
4

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
4

Oxidative Stress in Atherosclerosis.
Ajoe John Kattoor, Naga Venkata K Pothineni, Deepak Palagiri, Jawahar L Mehta. Curr Atheroscler Rep 2017
319
4

Diabetes, oxidative stress, and antioxidants: a review.
A C Maritim, R A Sanders, J B Watkins. J Biochem Mol Toxicol 2003
4




Glycaemic variability in diabetes: clinical and therapeutic implications.
Antonio Ceriello, Louis Monnier, David Owens. Lancet Diabetes Endocrinol 2019
142
3

Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Aidin Rawshani, Araz Rawshani, Stefan Franzén, Naveed Sattar, Björn Eliasson, Ann-Marie Svensson, Björn Zethelius, Mervete Miftaraj, Darren K McGuire, Annika Rosengren,[...]. N Engl J Med 2018
409
3


Inflammation, obesity, and thrombosis.
Fahumiya Samad, Wolfram Ruf. Blood 2013
190
3

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
3

Intensive glucose control and macrovascular outcomes in type 2 diabetes.
F M Turnbull, C Abraira, R J Anderson, R P Byington, J P Chalmers, W C Duckworth, G W Evans, H C Gerstein, R R Holman, T E Moritz,[...]. Diabetologia 2009
741
3


Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.
Rodney A Hayward, Peter D Reaven, Wyndy L Wiitala, Gideon D Bahn, Domenic J Reda, Ling Ge, Madeline McCarren, William C Duckworth, Nicholas V Emanuele. N Engl J Med 2015
363
3


Pathologic classification of diabetic nephropathy.
Thijs W Cohen Tervaert, Antien L Mooyaart, Kerstin Amann, Arthur H Cohen, H Terence Cook, Cinthia B Drachenberg, Franco Ferrario, Agnes B Fogo, Mark Haas, Emile de Heer,[...]. J Am Soc Nephrol 2010
654
3

Diabetes mellitus, fasting glucose, and risk of cause-specific death.
Sreenivasa Rao Kondapally Seshasai, Stephen Kaptoge, Alexander Thompson, Emanuele Di Angelantonio, Pei Gao, Nadeem Sarwar, Peter H Whincup, Kenneth J Mukamal, Richard F Gillum, Ingar Holme,[...]. N Engl J Med 2011
3

Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
Guang Liang, Lintao Song, Zilu Chen, Yuanyuan Qian, Junjun Xie, Longwei Zhao, Qian Lin, Guanghui Zhu, Yi Tan, Xiaokun Li,[...]. Kidney Int 2018
60
5


Biological markers of oxidative stress: Applications to cardiovascular research and practice.
Edwin Ho, Keyvan Karimi Galougahi, Chia-Chi Liu, Ravi Bhindi, Gemma A Figtree. Redox Biol 2013
370
3

Advanced glycation end products and diabetic complications.
Varun Parkash Singh, Anjana Bali, Nirmal Singh, Amteshwar Singh Jaggi. Korean J Physiol Pharmacol 2014
533
3



Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms.
John R Petrie, Tomasz J Guzik, Rhian M Touyz. Can J Cardiol 2018
258
3

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
3

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Faramarz Ismail-Beigi, Timothy Craven, Mary Ann Banerji, Jan Basile, Jorge Calles, Robert M Cohen, Robert Cuddihy, William C Cushman, Saul Genuth, Richard H Grimm,[...]. Lancet 2010
807
3

Genetics of diabetes mellitus and diabetes complications.
Joanne B Cole, Jose C Florez. Nat Rev Nephrol 2020
52
5

Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.
Yan Zheng, Sylvia H Ley, Frank B Hu. Nat Rev Endocrinol 2018
3

Advanced glycation end products: sparking the development of diabetic vascular injury.
Alison Goldin, Joshua A Beckman, Ann Marie Schmidt, Mark A Creager. Circulation 2006
3

Increased oxidative stress in obesity and its impact on metabolic syndrome.
Shigetada Furukawa, Takuya Fujita, Michio Shimabukuro, Masanori Iwaki, Yukio Yamada, Yoshimitsu Nakajima, Osamu Nakayama, Makoto Makishima, Morihiro Matsuda, Iichiro Shimomura. J Clin Invest 2004
3

Oxidative stress, aging, and diseases.
Ilaria Liguori, Gennaro Russo, Francesco Curcio, Giulia Bulli, Luisa Aran, David Della-Morte, Gaetano Gargiulo, Gianluca Testa, Francesco Cacciatore, Domenico Bonaduce,[...]. Clin Interv Aging 2018
766
3

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
3

Advanced glycation end products and oxidative stress in type 2 diabetes mellitus.
Kerstin Nowotny, Tobias Jung, Annika Höhn, Daniela Weber, Tilman Grune. Biomolecules 2015
392
3

Oxidative stress, insulin signaling, and diabetes.
Justin L Rains, Sushil K Jain. Free Radic Biol Med 2011
671
3



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.